MoneyWorks4Me

The company witnessed a 11.31% growth in the revenue at Rs. 21460.00 millions for the quarter ended September 2023 as compared to Rs. 19280.00 millions during the year-ago period.A humble growth in net profit of 20.22% reported in the quarter ended September 2023 to Rs. 3270.00  millions from Rs. 2720.00 millions.OP of the company witnessed a marginal growth to 7510.00 millions from 6310.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 21460.00 19280.00 11.31 42670.00 38610.00 10.52 76950.00 67420.00 14.14
Other Income 150.00 110.00 36.36 260.00 400.00 -35.00 820.00 2040.00 -59.80
PBIDT 7510.00 6310.00 19.02 14990.00 13250.00 13.13 25470.00 23040.00 10.55
Interest 770.00 620.00 24.19 1670.00 1130.00 47.79 2980.00 2360.00 26.27
PBDT 6740.00 5690.00 18.45 13320.00 12120.00 9.90 22490.00 20680.00 8.75
Depreciation 1920.00 1560.00 23.08 3750.00 3050.00 22.95 6720.00 6020.00 11.63
PBT 4820.00 4130.00 16.71 9570.00 9070.00 5.51 15770.00 14660.00 7.57
TAX 1550.00 1410.00 9.93 3070.00 3080.00 -0.32 5250.00 4750.00 10.53
Deferred Tax 720.00 710.00 1.41 1420.00 1520.00 -6.58 2510.00 2220.00 13.06
PAT 3270.00 2720.00 20.22 6500.00 5990.00 8.51 10520.00 9910.00 6.16
Equity 1692.30 1692.30 0.00 1692.30 1692.30 0.00 1692.30 846.20 99.99
PBIDTM(%) 35.00 32.73 6.93 35.13 34.32 2.37 33.10 34.17 -3.14
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..